My client is a global pharmaceutical company specialising in the discovery and development of therapies for life-threatening diseases.
A position has now become available for a high calibre pre-formulation scientist to join the Pharmaceutical Chemistry group.
The primary responsibilities include:
- Laboratory research into physical and chemical properties of pharmaceutical materials.
- Work with compounds during pre-clinical development phase from early discovery and lead opt to early toxicology and pharmaceutical studies.
- Develop drug forms and formulations to optimize exposure and stability.
- Regular involvement with other departments to drive efficiency and effectiveness of company drug development.
This position requires and exceptional pre-formulation scientist with the ability to work autonomously to achieve research success. Excellent understanding of solid-state chemistry including structure and physical aspects of small molecule pharmaceuticals, is essential. Experience working with pharmaceutical compounds at pre-clinical phase leading to toxicology and pharmacology studies is required.
In addition, the successful applicant will have a PhD (or equivalent in Chemistry, Physical Chemistry, Materials Science, Pharmaceutics or related field. Excellent laboratory skills in pre-formulation including solid-state (XRPD, DSC, TGA & DVS and analytical techniques including HPLC and NMR.
Applicants will be expected to be an expert in their field and display and excellent understanding of early stage pharmaceutical drug discovery.
This is an exceptional opportunity for an exceptional candidate.
The package includes and annual salary of c?45,000 within additional bonus package and excellent benefits.
Interested? Apply online now or contact PULSE Scientific on 01235 861732.
All applicants must be in a position to prove that they are legally entitled to work in the UK and accept employment without infringement of their immigration status.
HEALTH SERVICES/OUTCOMES RESEARCH
POSITIONS AND RESPONSIBILITIES: The Department of Pharmaceutical Systems and Policy at the West Virginia University (WVU School of Pharmacy seeks applications for an Assistant Professor to join our health services/outcomes research team. This 12-month tenure track position is available immediately. Primary responsibilities include graduate and professional program teaching, graduate student mentoring, and developing an independently funded research program in health services and outcomes research. Salary and start-up packages are competitive.
QUALIFICATIONS: Ph.D. or equivalent degree with a strong research focus in patient-reported outcomes (e.g., Health Related Quality of Life, patient satisfaction , or chronic disease epidemiology. Candidates should have a promise for excellence in research and teaching in relevant areas, as well as peer-reviewed publications. Experience and participation in funded research is an advantage and excellent communication skills are important. Candidates should interact effectively with collaborators from diverse disciplines and be eligible for appointment to the graduate faculty in order to teach and mentor graduate students engaged in health services and outcomes research.
APPLICATION: Interested persons should submit an application consisting of a letter of interest, curriculum vitae, and contact information for three professional references to: Usha Sambamoorthi, Ph.D., West Virginia University School of Pharmacy, PO Box 9510, Morgantown, WV 26506 or by e-mail to usambamoorthi@hsc.wvu.edu with a copy to acframe@hsc.wvu.edu. Applications will be considered as they are received and will be accepted until position is filled.
SCHOOL AND COMMUNITY: The School of Pharmacy has a nationally recognized Ph.D. graduate program in health outcomes research with 15 Ph.D. students, the majority of whom are supported by external research funding. It offers exciting opportunities through the Rational Drug Therapy Program which is supported by West Virginia state agencies, the AHRQ funded West Virginia Collaborative Health Outcomes Research of Therapies and Services (CoHORTS center, and the newly established Wigner Institute for Advanced Pharmacy Practice Education and Research. Established partnerships with the state Medicaid program and the state health insurance program, managed care organizations, several pharmaceutical companies, and the nearby National Institute of Occupational Safety and Health (N.I.O.S.H. and Mylan Pharmaceuticals offer potential opportunities for collaborative research. In addition, a newly launched School of Public Health and research faculty and graduate programs in business, communication, education, psychology, public administration, and sociology provide opportunities for multidisciplinary collaboration and research.
The School of Pharmacy is situated within a large state-assisted academic health sciences center which includes a 460-bed teaching hospital, a psychiatric hospital, rehabilitation hospital, and regional cancer center. West Virginia University (a Doctoral Research-Intensive University is the state's land-grant university with an enrollment of 29,000 students. WVU is located in Morgantown, a scenic rural area that has been featured in numerous publications for its high quality of life, cultural amenities, outdoor recreation, and is within easy driving distance to Pittsburgh, PA, and Washington, DC.
West Virginia University is an Equal Opportunity/Affirmative Action Employer. Women and minorities are encouraged to apply. The WVU Health Sciences Center is a smoke free campus. West Virginia University is the recipient of an NSF ADVANCE award for gender equity.
Apply Here
Post : Business Analyst in Pharmaceutical Research
Experience : 0 to 2 yrs
Job Desciption :
a. Track the pharmaceutical, biotech and medical devices industry, especially therapeutic areas/modalities of interest to our regular clients
b. Understand project brief given by clients/project leaders, create analysis plan, data requirements, research approach, and prepare reports or executive presentations with key insights and recommendations
c. Report to project leader/consultant and assist in executing or execute the projects completely depending on complexity and scale
Education :
M.Sc
- Bio-Chemistry,
Biotechnology
,
Life Science
Salary : INR 1,75,000 - 2,50,000 P.A. The CTC is exclusive of Performance Bonus
Desirable :
a. High level of comfort with MS Excel, Power Point, ability to perform basic calculations (basic financial, statistical and data manipulation understand sales and marketing performance metrics, basic data cleaning and organizing, ability to create meaningful charts/ visual representation to simplify complex analyses.
b. Web search, high level of familiarity with life sciences lexicon, regulatory framework for
pharmaceuticals and biotech
c. Attention to detail, accuracy, business relevance in analysis and report writing/executive
presentation skills
Location : Bangalore
Contact Details :
Executive Name : Ravi Prakash
Stratycon Business Solutions Pvt Ltd
Address : 14th cross, 2nd block,
Jayanagar Bangalore,Karnataka,India 560011
Email Address : raviprakash@stratycon.com
Deadline : 09.04.12
Salary: 110000
Description: The position requires demonstrated expertise in general mammalian toxicology. The position will oversee the conduct of general toxicity and drug safety studies in accordance with current scientific and applicable regulatory standards (ICH, FDA and GLPs and will monitor safety studies related to drug registration. Preferably, the incumbent will be specialized in one or more of the following areas: general safety evaluation, genetic toxicology, safety pharmacology, reproductive toxicology, carcinogenicity evaluation. In addition, he/she is expected to provide technical leadership in non-clinical drug safety assessment in support of worldwide clinical and preclinical R&D. The incumbent will be required to make both informal and formal presentations to internal staff and project teams and may be asked to assist with presentations to senior management as well as providing project team representation and active involvement in process development. The incumbent will be expected to contribute to the preparation of relevant sections of drug registration submissions. Knowledge of the drug development process and experience in interaction with scientific disciplines such as pharmacokinetics, metabolism, medical research and clinical pharmacology are essential. A successful track record of toxicology testing program management, innovative thinking, execution and timely delivery of reports and regulatory submissions is helpful. PRINCIPAL ACCOUNTABILITIES: Direct responsibilities will include, but are not limited to the following: o Participation in the evaluation and qualification of CROs. o Assists in the design of study protocols for nonclinical toxicology and safety pharmacology studies for conduct at CROs. o Conduct, monitor, and manage toxicology studies at CROs. This will involve limited travel (~10% . o Reviews study data and reviews/revises final study reports for department authorization. o Assists in the preparation of the nonclinical safety sections of regulatory submissions for registration/marketing authorizations of new drug products o Provide technical expertise to support project teams goals and objectives. Educational Requirements A minimum MS in pharmacology, toxicology, biochemistry or related science is required. At least 5 - 7 years industry (preferably pharmaceutical experience with 3 + years' experience in the conduct of mammalian toxicology studies. Required Experience & Technical Requirements o Knowledge and expertise in toxicology and standard and alternative toxicology test methods is necessary to address the range of varied chemical substances that will need to be tested and to interpret and report the study results. o Knowledge of GLPs and direct experience in toxicology testing and/or study management is needed to successfully prepare protocols, implement, and adequately oversee the toxicity studies conducted by CROs and to understand the relative strengths and limitations of testing methods as they relate to hazard identification. o Knowledge and experience in internet/database searching is necessary to develop information that will allow the avoidance of duplicative and unwarranted use of animals in toxicology testing and to assure up-to-date and complete knowledge of available toxicology data and regulatory changes and initiatives. This includes but is not limited to experience in successfully searching FDA, EMEA, WHO, NTP, ASTDR, IARC, NLM databases. o Concise and accurate writing skills and clear and effective oral presentation skills.
Contact:
dld@judge.com
This job and many more are available through The Judge Group. Find us on the web at
www.judge.com
Biotecnika Info Labs Pvt Ltd, Bangalore is a Parent Company which runs India’s Largest Biosciences Career & education Portal. Biotecnika is where in technology meets life sciences.
“We are a fast growing Bio-techno-media company with extremely talented and fun Loving people you would love to work with. Biotecnika is run by a group of Doctorate & post Doctorates of lifesciences & together we help in the upliftment of postgraduates from any lifesciences background. If you do not like processes, hate pyramid type organizations; love creativity, innovation and fun at work; you will love it here. You will find a very flexible work environment, which treats people like human beings”
- Post: Business Development Executive
- Company Name: Biotecnika Info Labs Pvt Ltd
- Location: in Bengaluru/Bangalore
- Experience: 0 to 3 yrs
- Salary: INR 1,75,000 - 2,50,000 P.A
- Opening(s : 5
Qualification & Duties
- Must be a MSc graduate in Bioscience
- 0 - 3 years Sales experience.
- MBA preferred
- Good written and oral communication
- Client follow ups
- Candidate should be willing to sell services and product.
- Candidates have to generate leads, qualify the leads on the sales strategies, identify the potential client, client interaction and maintain client relationship.
- Understanding the requirement of client and offering them with the appropriate services and product.
- Follow up with clients.
- Ability to meet multiple objectives within an organization.
- Work on Online marketing, Social Media Marketing, Email marketing, Tele Marketing as well as Field marketing
- Selling should be your signature statement.
- Maintaining relationship with clients and providing business leads, client interaction, team building, follow up with clients.
- Identify potential clients; manage existing account/customer relationships.
- Understanding the requirements of the clients & positioning an appropriate Solution
- Should be able to travel on demand as per the Company Policy.
- Liaisoning with Colleges / institutes for upliftment of biosciences
Desired Candidate Profile
Education:(UG - Any Graduate - Any Specialization, B.Com, B.B.A, B.Pharma, B.Sc,
B.Tech
/B.E. AND (PG - MBA/PGDM - Advertising/Mass Communication, International Business, Marketing, Other Management,
M.Tech
- Bio-Chemistry/Bio-Technology, Biomedical,
M.Sc
- Bio-Chemistry
- A minimum of 0 - 3 years of marketing experience
- Good organizational skills and the ability to understand detailed information.
- Basic IT and numeric skills.
- Good interpersonal skills to form effective working relationships with people at all levels.
- A proven track record of 'making a difference'.
- Creative, resourceful, detail-oriented, highly organized.
- Excellent verbal and written communication skills.
- Good Presentation skills.
- Time Management Skills.
- The potential to handle a leadership role.
- Candidate should have pleasing personality with excellent communication skills (Verbal & Written .
- Only candidates who can relocate to bangalore may apply
Executive Name:Sylvia Fernandes
Contact Company: Biotecnika
Address: #2628, 4th Floor 27th Main, Sector 1 HSR Layout, Landmark - CPWD Quarters BANGALORE,Karnataka,India 560102
Apply to Email Address :
jobs@biotecnika.org
Telephone: 80-91-65705331
Reference Id: MAR-10-BDE
It's hard to know these days which way the proverbial worm is turning when it comes to shifts in drug policy. Election years tend to do that. Despite an historical turn of events in Central America which saw Presidents of drug trafficking nations come together to call for world wide decriminalization of drugs, in an effort to end the violence and corruption of the drug trade, the US continues to demur, absurdly claiming that the "War on Drugs" has been a success. Even stranger is Canada's recent announcement that they plan to follow the US model of a "tough on crime" approach to drug policy, which threatens to swell their correctional system in the same ways as in the US. Still, good news abounds with recent studies showing that LSD can cure alcoholism, psychedelics can cure PTSD, and cannabis smoking is not nearly as harmful as the prohibition governments claim. ~ CS
Google+ Presents:
It's Time To End The War On Drugs
To liberalise or prohibit, that is the question. And to answer it the masters of live debate have joined forces with the masters of web technology to create a never-seen-before combination of Oxford debating and Silicon Valley prowess.
Prohibitionists argue that legalising anything increases its consumption. The world has enough of a problem with legal drugs like alcohol and tobacco, so why add to the problem by legalising cannabis, cocaine and heroin?
The liberalisers say prohibition doesn’t work. By declaring certain drugs illegal we haven’t reduced consumption or solved any problem. Instead we’ve created an epidemic of crime, illness, failed states and money laundering.
Julian Assange and Richard Branson; Russell Brand and Misha Glenny; Geoffrey Robertson and Eliot Spitzer. Experts, orators and celebrities who’ve made this their cause – come and see them lock horns in a new Intelligence?/Google+ debate format. Some of our speakers will be on stage in London, others beamed in from Mexico City or Sao Paulo or New Orleans, all thanks to the “Hangout” tool on Google+.
The web will have its say, and so can you at the event in London. Be part of the buzz of the audience, be part of an event beamed across the web to millions. Come and witness the future of the global mind-clash at the first of our Versus debates, live at Kings Place
Source:
Intelligence 2 from Google +
North America
America's plague of incarceration
The message is (or should be deeply disturbing. Shouldn't the USA be ashamed at having the world's largest prison system and highest incarceration rate (754 per 100 000 people ? The richest country in the world has so many of its citizens in prison that it can't afford to house them with even basic minimum medical care (more than half of all prisoners have mental health or drug problems . Prison overcrowding itself has become so terrible in California, that in May, 2011, the US Supreme Court affirmed a lower court order that California release some 46 000 prisoners because of the inhuman conditions under which they were being held. In the Court's words, “A prison that deprives prisoners of basic sustenance, including adequate medical care, is incompatible with the concept of human dignity and has no place in a civilised society.”
Source:
"
A Plague of Prisons: The Epidemiology of Mass Incarceration in America,"
The Lancet.
International Women's Day: U.S. Must Address Impact of Mass Incarceration on Women.
More women are ending up behind bars than ever. Between 1980 and 1989, the number of women in U.S. prisons tripled. And the number of women in prison has continued to rise since. In the last 10 years, the number of women under jurisdiction of state or federal authorities
increased 21 percent to almost 113,000. During the same time period, the increase in the number of men in prison was 6 percentage points lower, at about 15 percent. The increase in women in the federal population was even larger- over 41 percent from 2000 to 2010.
Most women are incarcerated for nonviolent offenses. Over one-fourth are in prison for a drug offense, while 29.6 percent were convicted of a property crime. Addiction plays a large part in a number of women's property crimes, and a lack of available or appropriate treatment only serves to drive their contact with the justice system.
Source:
Justice Policy Institute
From Cell to Screen: The Story of Mumia Abu-Jamal -- Part I
Stephen Vittoria is that rare commodity in Hollywood today: a filmmaker with a conscience. To be more precise, a filmmaker with a strong political conscience. After making two feature films,>Black and White& Hollywood Boulevard (1996 , as well as three feature documentaries:Save Your Life -- The Life and Holistic Times of Dr. Richard Schulze (1998 ,;Keeper of the Flame (2005 and the award-winning art house hit One Bright Shining Moment: The Forgotten Summer of George McGovern (2005 , a portrait of the South Dakota senator who tried to unseat Richard Nixon from the White House in 1972.
For his latest exploration into America's socio-political landscape, Vittoria joins forces with radio producer Noelle Hanrahan to bring Long Distance Revolutionary, the story of Mumia Abu-Jamal, to the screen. Born Wesley Cook in Philadelphia, Abu-Jamal made his name as a tireless writer and journalist during the racially-charged 1970s that often portrayed the City of Brotherly Love as anything but. With his intense coverage of the MOVE organization, a black empowerment group whose ongoing battle with the police and city hall came to a fiery end in 1985, Abu-Jamal become a constant thorn in the side of the city's powerful establishment. Things came to a sudden head for Abu-Jamal himself on the evening of December 9, 1981 when he was accused of murdering a Philadelphia police officer. He received a death sentence the following year, and has been on Pennsylvania's death row until early this year, when his death sentence was commuted to a life sentence in December, 2011.
Abu-Jamal's case remains one of the most controversial and heatedly debated in American legal history, with participants on both sides either protesting his innocence in the murder of Officer Daniel Faulkner or his absolute guilt with equal passion and more often, great vehemence.
Source:
Huffington Post
What’s In a Name? A Lot, When the Name is “Felon”
At a
recent conference of journalists at John Jay College, I raised an issue I have about language in the media: the frequent use of the word “felon” to describe a person who has been convicted of a crime.
“Felon” is an ugly label that confirms the debased status that accompanies conviction. It identifies a person as belonging to a class outside many protections of the law, someone who can be freely discriminated against, someone who exists at the margins of society.
In short, a “felon” is a legal outlaw and social outcast.
Source:
The Crime Report
Addiction: Medical Disease or Moral Defect?
Scientific theories that addiction hijacks the brain have just increased the stigma that they were meant to stop. At least in the moralistic bad old days, addicts were still viewed as having free will. Here's an alternative to both of these no-win approaches.
Source:
The Fix
Scientists Explore Hallucinogen Treatments for PTSD, Sex Abuse Victims
Mind-altering compounds, such as LSD and psilocybin, stirred controversy in the 1960s. As the counter-culture’s psychedelic drugs of choice, the widespread use - and abuse - of hallucinogens prompted tougher anti-drug laws.
Salary: Open
Description: Leading pharma client seeks a Chemist for a contract opportunity. Tests and interprets results for raw materials, active pharmaceutical ingredients, finished pharmaceutical products, and stability samples.Interprets compendial and internal monographs, NDAs and Laboratory Quality Standards. Qualifications: BS/MS in science, preferably in Chemistry or Biology, with 2 or more years of pharmaceutical laboratory experience. Basic knowledge of analytical instrumentation with strong technical and interpersonal skills. Strong working knowledge of raw materials, KF, Dissolution, HPLCs(Waters .
Contact: dmiddleton@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
TODAY is my last day at Goldman Sachs. After almost 12 years at the firm — first as a summer intern while at Stanford, then in New York for 10 years, and now in London — I believe I have worked here long enough to understand the trajectory of its culture, its people and its identity. And I can honestly say that the environment now is as toxic and destructive as I have ever seen it.To put the problem in the simplest terms, the interests of the client continue to be sidelined in the way the firm operates and thinks about making money. Goldman Sachs is one of the world’s largest and most important investment banks and it is too integral to global finance to continue to act this way. The firm has veered so far from the place I joined right out of college that I can no longer in good conscience say that I identify with what it stands for.
It might sound surprising to a skeptical public, but culture was always a vital part of Goldman Sachs’s success. It revolved around teamwork, integrity, a spirit of humility, and always doing right by our clients. The culture was the secret sauce that made this place great and allowed us to earn our clients’ trust for 143 years. It wasn’t just about making money; this alone will not sustain a firm for so long. It had something to do with pride and belief in the organization. I am sad to say that I look around today and see virtually no trace of the culture that made me love working for this firm for many years. I no longer have the pride, or the belief.
But this was not always the case. For more than a decade I recruited and mentored candidates through our grueling interview process. I was selected as one of 10 people (out of a firm of more than 30,000 to appear on our recruiting video, which is played on every college campus we visit around the world. In 2006 I managed the summer intern program in sales and trading in New York for the 80 college students who made the cut, out of the thousands who applied.
I knew it was time to leave when I realized I could no longer look students in the eye and tell them what a great place this was to work.
When the history books are written about Goldman Sachs, they may reflect that the current chief executive officer, Lloyd C. Blankfein, and the president, Gary D. Cohn, lost hold of the firm’s culture on their watch. I truly believe that this decline in the firm’s moral fiber represents the single most serious threat to its long-run survival.
Over the course of my career I have had the privilege of advising two of the largest hedge funds on the planet, five of the largest asset managers in the United States, and three of the most prominent sovereign wealth funds in the Middle East and Asia. My clients have a total asset base of more than a trillion dollars. I have always taken a lot of pride in advising my clients to do what I believe is right for them, even if it means less money for the firm. This view is becoming increasingly unpopular at Goldman Sachs. Another sign that it was time to leave.
How did we get here? The firm changed the way it thought about leadership. Leadership used to be about ideas, setting an example and doing the right thing. Today, if you make enough money for the firm (and are not currently an ax murderer you will be promoted into a position of influence.
What are three quick ways to become a leader? a Execute on the firm’s “axes,” which is Goldman-speak for persuading your clients to invest in the stocks or other products that we are trying to get rid of because they are not seen as having a lot of potential profit. b “Hunt Elephants.” In English: get your clients — some of whom are sophisticated, and some of whom aren’t — to trade whatever will bring the biggest profit to Goldman. Call me old-fashioned, but I don’t like selling my clients a product that is wrong for them. c Find yourself sitting in a seat where your job is to trade any illiquid, opaque product with a three-letter acronym.
Next Page »
- 1
- 2
Greg Smith is resigning today as a Goldman Sachs executive director and head of the firm’s United States equity derivatives business in Europe, the Middle East and Africa.
The institute offers an MSc in ' Bioinformatics and Biotechnology '. The course will provide competence in both Biotechnology and computational biology/ Bioinformatics by providing training in the areas of cell and molecular biology , computer science, statistics, Bioinformatics and so on (syllabus available below .
IBAB has been running a Postgraduate Diploma in Bioinformatics since 2002, and the 11th batch is currently doing its coursework. It has also been running a Postgraduate Diploma in Laboratory Biotechniques since 2004, and the 8th batch has completed its coursework. The two popular programmes are now being discontinued to enable the faculty to focus on the MSc programme.
Every student is provided
- Access to a fully loaded high-end PC and extensive access to the internet for the entire duration of 2 years.
- Lectures are delivered by in-house faculty, distinguished academics and industry scientists from leading institutions/companies within the country or from abroad.
- A significant amount of time is devoted to learning through material available on-line, journals, seminars, tutorials, group discussions etc.
- Thus the extensive lecture/tutorial program is supplemented by an enabling environment and associated self-learning through assignments and project work.
The 2 year MSc course is structured into 4 semesters, as below.
1. ADMISSION PROCEDURE
- Application processing fees (non-refundable
- Rs. 500/- for students from India and non-industrialized countries
- Rs. 1000/- for NRI/Foreign students from industrialized countries
A Demand Draft for the above mentioned amount in favour of 'Institute of Bioinformatics and Applied Biotechnology ' payable at Bengaluru needs to be sent to the institute (please see next section for other documents that also have to be submitted .
2. Application form
Fill up all details on-line and seprately send DD, 2 passport size photos and photocopies of marksheets to IBAB by post/courier. THIS IS THE ONLY OPTION FOR APPLYING. There is no hardcopy form available by downloading or by requesting a copy.
The online form will be processed only on receipt of the DD.
3. List of necessary documents
- Regular candidates:
- Photocopies of all certificates/marksheets
- NRI/Foreign candidates:
- Photocopies of all certificates/marksheets
- Proof of NRI/Foreign status (stamped page from passport
DO NOT send any original certificates/marksheets.
4. Important information:
a. Date of online test: To be announced later.
b. Date of Interview: You will be given a date between 16-19 July 2012. In case you have a problem with your allotted date, write to msc2012@ibab.ac.in or call 080-285 289 00 or 01, 9611 872 946, 900 829 6547 between Monday and Friday from 10:00am to 5:30pm.
c. If a seat is offered, the last date for accepting it is 5 days after being intimated. At this time a token sum of Rs. 20,000/- (adjustable against the fees due at the time of joining has to be paid to the institute.
d. Course commences: 18 August 2012.
5. Eligibility for the course
a. A recognised BSc degree in any branch of science or technology, viz. life sciences ( Agriculture , Biotechnology etc. , physics, chemistry, mathematics, statistics, engineering, pharma, veterinary or medicine with minimum of 55% marks. Thus, the following degree holders may apply: BSc, BTech, BE, MBBS, BDS, etc. Please contact IBAB in case you have a doubt about whether you are eligible.
b. Students awaiting their results can also apply, provided their average percentage of previous semesters/years is at least 55%.
c. There is no age limit.
Fees
Application processing fees (non-refundable :
1. Application processing fees (non-refundable :
Rs. 500/- for students from India or non-industrialized countries
Rs. 1000/- for NRI/Foreign students from industrialized countries
A DD for the above mentioned amount in favour of “Institute of Bioinformatics and Applied Biotechnology ” payable at Bengaluru, should be sent to IBAB by post/courier or submitted in person after filling up the form online. Please note the other documents that also have to be submitted (2 passport photos and photocopies of marksheets .
2. Course fees per semester:
- For Indian students and students from non-industrialized countries.
- Academic fees: Rs. 50,000/- per semester. This includes tuition fees, laboratory fees, software fees and library fees. This has to be paid within a week of the joining date for each semester. In addition, there is a security deposit of Rs. 20,000/- (refundable only on completion of the course to be paid upon joining.
Please download the details and schedule of payment of course fees and hostel fees.
Partial waiver of fees through scholarships in case of a few deserving students may be feasible.
For NRI/Foreign students from industrialized countries
- Academic fees: Rs. 75,000/- per semester. This includes tuition fees, laboratory fees, software fees and library fees. This has to be paid within a week of the joining date for each semester. In addition, there is a security deposit of Rs. 30,000/- (refundable only on completion of the course to be paid upon joining.
Please download the details and schedule of payment of course fees and hostel fees.
Contact for further queries (between 10:00am and 5:30 pm, Mon-Fri : 080 - 285 289 00/01/02.
Mobile: 9611 872 946 / 900 829 6547
You can also send an email to msc2012@ibab.ac.in
Syllabus
- The syllabus is liable to change over time. Please download the current syllabus from here.
Salary: Open
Description: Leading biotechnology client has an exciting opportunity for Manager/Sr Manager Compliance. Successful candidate possesses the knowledge and capability to develop, audit, and assess quality systems and compliance required to support the development, manufacture, testing, and commercial distribution of API and finished pharmaceutical and medical device products. *** Willingness to travel up to 30% (Globally **** Specific Duties: 1. Serves as the company point of contact for FDA and all regulatory inspections. Issues daily minutes and assures timely communication of activities to senior management. Organizes and coordinates activities associated with "back room" preparation 2. 3. Ensure timely follow up and closure of all 483 commitments and other regulatory observations 4. Independently audits and assesses Quality Management Systems of suppliers and CMOs to ensure compliance with FDA 21 CFR Parts 11, 210, 211 and 820; ICH guidelines, ISO and other applicable regulatory requirements 5. Participates on project teams representing Quality and assures compliance to all internal and regulatory requirements. Projects including: CSV, process validation, facility and equipment qualification, etc. 6. Works collaboratively with other functions within in the improvement and incorporation of industry best practices for the quality systems noted above 7. Assists in the development of training programs as required to support the implementation and maintenance of quality systems within realm of responsibility 8. Provides reports and trends to the Management Representative to help in the preparation of Management reviews 9. Ensures systems are in place to monitor closure of Corrective and Preventive Actions (CAPA 10. Responsible for issuance, coordination, and follow up on all Field Alert Reports (FAR or equivalent non-FDA regulatory reporting requirements 11. Executes and manages all product recalls in compliance with local regulatory requirements 12. Develops metrics and data collection processes to ensure appropriate governance and management oversight 13. Develops and implements an active regulatory surveillance group that allows proactive plans for new or changing regulations. 14. Drive continuous improvement of the quality performance of business processes via Quality Plan implementation III. Education, Special Skills and Experience: Bachelor's degree in Chemistry, Engineering or other Physical Sciences Minimum 10 years of experience in medical device and/or pharmaceutical manufacturing, QA or QC assurance roles 5 years of direct QA experience developing and implementing quality systems in the medical device and/or pharmaceutical industry Expertise in FDA 21 CFR Parts 11, 211, 210 and 820 and ICH quality system requirements Ability to work collaboratively across departments/functions and interact in a tactful, professional and effective manner strong project management skills Ability to manage and prioritize multiple tasks Experience in using computer programs (MS Word, Excel, and Access Strong communication skills (both written and orally with external and internal customers Preferred: Experience with TrackWise Quality Management Software ASQ Certified Quality Engineer (CQE and experience with Six Sigma methodologies Certified Project Management Professional (PMP
Contact: dmiddleton@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Salary: Open
Description: We are currently seeking a talented and motivated Project Toxicologist to join our preclinical development team, reporting to the Associate Director, Toxicology. This position is responsible for all aspects of preclinical toxicology related to the development of novel antibody therapeutics. Essential Functions: - Design, implement, and monitor outsourced toxicology studies - Critically review toxicology data and provide input on safety assessments - Prepare toxicology-related documents for internal reports and regulatory submissions. - Participate in cross-functional development-team activities. - Other responsibilities and duties as required Experience: - Ph.D. or DVM, with 3 to 5 years of pharmaceutical/drug development experience - DABT certification desirable but not required Required Skills: -Ability to apply principles of toxicology, pharmacology, pathology, animal biology and analytical sciences to advance drug development efforts. -Strong oral and written communication skills -Strong working knowledge of Good Laboratory Practice regulations -Ability to solve problems creatively to meet aggressive development timelines in a matrix environment We offer a competitive compensation and benefits package including stock incentives, 401k with company match as well as the expected health and welfare benefits. Comprehensive relocation benefits are available, as required.
Contact: tcilmi@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
The Daily Mail today put a dampener on the approaching Mothers’ Day by telling us that it is our mum’s fault if we are “losing the fight against the flab”. The newspaper said that a new study has shown that our mother’s lifestyle may leave us “programmed to be fat”.
Thankfully for our relationships with our mums, the research does not actually say this. The study in question aimed to investigate whether DNA modifications in early life are linked to our size and body composition in later childhood. The modification in question does not change the underlying genetic code but it does decreases the amount of proteins the body makes using the instructions in our genes.
After stringent testing the researchers found only one significant link, between the modification of one gene and height rather than weight. None of the links between DNA modification and body mass index (BMI stood up to stringent testing, and even the study’s authors note that the study cannot prove that the DNA modification at birth definitely directly affected height. For the time being, it is probably best to work on improving our health and wellbeing by addressing the lifestyle factors that we can change.
Where did the story come from?
The study was carried out by researchers from Newcastle University and other research centres in the UK. It was funded by the Biotechnology and Biological Sciences Research Council, Special Trustees of Newcastle Hospitals, the UK Medical Research Council, the Wellcome Trust, the University of Bristol, Asthma UK, the medical nutrition firm Nutricia UK, and the pharmaceutical company Novo Nordisk.
The study was published in the peer-reviewed open access scientific journal PLoS One.
The story was covered by articles from the BBC News and the Daily Mail, which both featured headlines focusing on how factors in the womb might influence obesity. However, the study found only one outcome to be statistically significant – a link with height.
The BBC did state that only one link stood up to rigorous testing but did not say this was a link with height rather than BMI or body fat levels.
The study did not look at obesity itself, rather it looked at BMI and fat mass. It did not classify the children into weight categories such as ‘overweight’ or ‘obese’ in its analyses, nor did it look at ability to lose weight, as suggested by the Daily Mail’s headline about ‘losing the fight against the flab’.
Both sources mention factors that might influence these DNA modifications in the womb, such as diet, exercise, smoking or drinking alcohol. However, it is important to note that the study did not look at why the DNA modifications might have occurred, so they cannot be attributed to these or any other factors based on this study.
What kind of research was this?
The body uses DNA as the blueprint for producing a range of important proteins. Sections of DNA produce individual proteins are known as genes.
In this study, researchers looked at a type of DNA modification called ‘methylation’, where a chemical compound called a methyl group becomes attached to the outside edge of a DNA strand. This process does not change the underlying genetic code, but it does reduce the amount of protein the body produces using nearby genes. It is one of the ways the body can control how much of each protein is produced.
The study looked at whether the levels of DNA methylation shortly after birth had any relationship to body size later in childhood. To examine the issue it analysed information collected in two cohort studies: the Preterm Birth Growth Study (PBGS , and the Avon Longitudinal Study of Parents and Children (ALSPAC . The level of methylation after birth was calculated using analyses of umbilical cord blood.
What did the research involve?
The researchers initially wanted to identify which genes might be related to BMI composition in childhood. To do this they looked at a group of 24 children in the PBGS study whose BMIs had been measured when they were aged between 11 and 13 years (average 12.35 years . They then looked at how active various genes were in the children with the highest BMIs and those with the lowest BMIs. They did this to identify genes that could be affecting BMI, to target these genes for investigation in the next phase of the study.
A selection of the genes identified through this first phase of the study were then assessed in a second phase of the study, to see whether these differences in gene activity in later childhood and changes in BMI might be related to the level of DNA methylation that was in place from the time of birth. The genes selected for this second phase were selected because they could be assessed with the technology the lab had available.
In this second part of the study the researchers looked at the levels of DNA methylation in blood collected from the umbilical cord of 178 babies taking part in the ALSPAC study. These babies had been followed up through childhood, and had data on their body composition, including BMI, fat mass, lean mass, and height at about age nine (average age 9.8 years . Methylation was measured in up to three places within the selected genes. The researchers analysed whether the level of methylation of these genes at birth was related to body composition at age nine.
What were the basic results?
In the first part of their study, looking at children aged about 12 years, the researchers found that 514 genes had different levels of activity in those with higher BMIs and lower BMIs. From the genes they identified they selected 29 of these genes to look at in the second part of their study.
They found that four of these 29 genes were not methylated in the 178 cord blood samples tested, so they did not study these genes any further. The methylation levels of nine of the remaining genes were each related to at least one measure of body composition at age nine.
However, once the researchers took into account the number of statistical tests they had performed, the methylation level of only one gene was found to have a statistically significant association with a body composition measure. The gene in question was called ALPL, and higher levels of methylation of this gene in umbilical cord blood at birth were associated with being shorter at age nine. Each 1% increase in DNA methylation of ALPL was linked with a 0.15% decrease in height at age nine.
How did the researchers interpret the results?
The researchers conclude that the patterns of DNA methylation in cord blood showed some association with body size and composition in childhood. However, they note that their study is not able to say whether the changes in DNA methylation seen actually cause the differences in body size and composition in childhood, and further research is needed to investigate this.
Conclusion
In recent years there has been lots of scientific and public interest in how events early in the womb may relate to our health in later life. In this vein, the national press have picked up on this study, which investigated whether DNA modifications during early life might impact on later body size and composition in childhood.
While these press narratives have given the impression that this study has linked particular environmental exposures in the womb such as maternal smoking and drinking can lead to DNA modifications and later obesity, this is not the case:
- The news sources mention factors that might influence these DNA modifications in the womb, such as the mother’s diet, exercise, smoking, or drinking alcohol. However, it is important to note that the study did not look at how or why the DNA modifications might have occurred, so they cannot be attributed to these or any other factors based on this study.
- The study did not look at obesity, rather it looked at BMI and fat mass. It did not classify the children into weight categories such as ‘overweight’ or ‘obese’ in its analyses. It also did not look at whether participants had difficulty losing weight, as suggested by the Daily Mail’s headline about why some people may be ‘losing the fight against the flab’.
- The study was relatively small, and only looked at methylation of a small number of genes. Only one association between methylation of one gene at birth and height remained statistically significant after stringent testing. However, the authors themselves note that their study cannot prove that the DNA methylation pattern at birth caused the differences in height seen.
- None of the links between DNA methylation at birth and BMI or fat mass remained statistically significant in stringent tests. This means that they cannot be said to be real associations, as they may therefore have just occurred by chance.
If the results of the current study can be confirmed in other studies, researchers will need to try and work out if the link is causal. Even if the link is confirmed and found to be causal (and it is a big IF , it is not clear what if anything could be done to alter this.
For the time being, we are probably best working on improving our health by addressing the factors that we know we can change, rather than blaming our Mums for making us ‘programmed to be fat while in the womb’. Not a nice sentiment in the run-up to Mother’s day.
Analysis by Bazian
Links To The Headlines
Study links womb environment to childhood obesity. BBC News, March 15 2012
Losing the fight against the flab? It's your mum's fault! Research shows we are programmed to be fat while in the womb. Daily Mail, March 15 2012
Links To Science
Relton CL, Groom A, St. Pourcain B et al. DNA Methylation Patterns in Cord Blood DNA and Body Size in Childhood. PLoS ONE, 2012 7(3 : e31821
I am looking a Medical Writer to research and write a variety of materials to the highest standard. You will have some medical communications writing experience or PR experience. You should come from a science background, have positive attitude, along with being client and opinion-leader friendly.
Key Skills:
·Research, write, edit and proof copy to the highest standard (scientific and grammatical for a full range of medical education and communications materials including scientific abstracts papers, posters, oral presentations, print items, and multimedia.
·Develop and implement project schedules.
·Support the delivery of scientific meetings including pre-meeting and on-site activities.
·Should be able to demonstrate familiarity with the industry code of practice.
·To review scientific content for range of medical communications, according to client needs, internal quality standards and agreed specifications, budgets and timeframes.
Salary : 30k-38k (depending on experience
Salary: Open
Description: Leading pharma client has a great opportunity for a senior SAS programmer supporting clinical trial reporting and analysis. The individual will lead development of programs to create/validate analysis datasets and outputs for submissions and other deliverables including Clinical Study Reports, Clinical Summaries of Safety and Efficacy, electronic submission files, publication support and ad hoc requests.The individual will be responsible for the production of timely, quality and compliant deliverables. Qualifications/Responsibilities: Master's Degree in Computer Science, Statistics, Applied Mathematics, Biological Sciences, or Engineering Experience in SAS programming with clinical trial data including programming and validation of datasets, tables, graphics, and statistical analyses 5+ years' experience using SAS in clinical trials setting A high level of proficiency with SAS reporting writing, SAS macro language, and SAS statistical procedures; proficiency with SAS/GRAPH is desired CDISC knowledge and experience is highly preferred Good communication skills enabling effective participation in cross functional environment; demonstrated history of teamwork and collaboration
Contact: dmiddleton@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Salary: Open
Description: The role of the Discovery Logistics Specialist is to provide logistics support to enable the externalization of Discovery programs and capabilities. The incumbent in this position is accountable for interfacing with Discovery project teams, vendors/collaborators, and other departments, to coordinate, and manage, and track Discovery sample shipments to and from external sourcing partners. Some of the responsibilities in this position include but are not limited to the following: Coordinating and tracking sample shipments from program teams to partner sites, including gathering and processing supporting documentation (MSDS, prototype documentation, HTS codes, etc. for shipping samples between sites and to domestic/international partner sites Ordering compounds and biological materials from internal and external sources, confirming sample availability, logging of samples into appropriate databases, packaging and delivering samples to shipping specialists Ad hoc compound and sample management support, excluding weighing and registration of compounds Qualifications Education: -Bachelor's degree in science/engineering, preferably chemistry or biology Required: -Strong organizational skills -Flexibility interest in working on a variety of projects -Ability to communicate clearly and candidly with internal and external program team members -Ability to work independently Preferred: -Prior experience in organic chemistry -One (1+ years pharmaceutical/ biotech industry experience
Contact: dmiddleton@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Salary: $90k
Description: Manager EH&S needed for pharmaceutical company. Incumbent will be responsible for leadership of all facility Safety and Environmental Control functions. Ensures compliance to all applicable Corporate, Federal, State and local safety, industrial hygiene, and environmental regulations/policies. Provides technical expertise to facility, interpreting data, identifying hazards, assessing risk and implementing solutions to prevent serious injury, environmental impact and property damage. Minimum 5 years of experience in loss control, safety, industrial hygiene, environmental safety, emergency response, or related fields required. Minimum 2 years supervisory experience required. Requires bachelors degree in science, engineering or equivalent. Knowledge of chemistry and EHS related areas. Excellent verbal and written communication and interpersonal skills. Experience in basic computer systems and experience in Microsoft programs to include Excel, Access and Word.
Contact: LMANFREDY@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Salary: 90-140k
Description: A major pharmaceutical company in the Northeast is looking for a Principal Medical Writer. The ideal candidate will have a PhD in a Life Science and at least 7 years' relevant industry experience. Must have prior experience in the preparation of NDA documentation. Must be fully conversant with Federal Regulations governing the submissions process. Prior experience in the preparation of electronic submissions required. Must have a proven ability to lead/mentor more junior personnel. Must have strong organisational and communication skills. Oversee medical writing projects. Ensure adherence to all relevant regulations and guidelines. Coordinate activities of in-house and freelance medical writers. Advise relevant personnel on content and format of documents being prepared for submission. Mentor junior members of medical writing team. Review edit and format clinical study protocols. Coordinate document revision process between reviewers departments and business partners. Collaborate with other functional areas to prepare electronic submissions. Maintain knowledge of product areas current trends and literature.
Contact: LMANFREDY@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Salary: Open
Description: Leading pharma client has a contract opportunity for a recent Science grad. This position is an entry level position that requires excellent technical writing skills, including the ability to evaluate data and summarize in a clear and concise form. The role contains a mixture of administrative tasks and technical writing assignments. Management of the agenda for a daily team meeting and coordination of daily agenda emails, review of documentation submitted for the daily meeting and coordination of follow up for each item, initiation of electronic investigations and notification to responsible personnel, scanning of documentation for investigation reports and upload to electronic repositories, daily and weekly summaries, preparation of metrics (including graphical presentations for periodic review. In addition, the position also includes responsibility to perform root cause analysis investigations and documentation of the investigation findings in the investigation report. Qualifications: BS/BS Biology/Biotech/Biochemistry/Chemical Engineering Proficiency in MSOffice software is required. Knowledge of a variety of computer software programs is a plus, including: LIMS, MiniTab, SAP, electronic document repositories, etc. The position requires well developed organizational, time management and written/oral communication skills. Please contact: Deirdre Middleton 1-888-228-7162 x1581 610-667-7700 x1581 dmiddleton@judge.com
Contact: dmiddleton@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
 |
There is a concerted effort currently underway to demonize all things meat, regardless of how it is raised or produced, by blaming disease, obesity, and now even global warming, on human meat consumption. And a recent paper put out by S. Matthew Liao, a professor of... |
Salary: $90,000 to $140,000
Description: Position will direct, plan, administer, and provide Leadership for the activities of personnel in multiple disciplines with various levels of responsibilities. Role is required to develop and authorize the implementation of site policies and procedures (SOPs to assure compliance with government requirements, and corporate policies. Director participates as a member of the site Senior Management Team developing site strategies, policies, and successfully implementing the same. This role interacts with other Quality Directors to assure alignment of policies and procedures between and within sites. Individual must be able to representsaid company at the Director level with customers and regulatory agencies. Essential Duties and Responsibilities Site Compliance: ensure site is compliant with applicable quality and regulatory requirements. Support FDA and Customer Audits. Testing and Product Disposition: assure that all testing (chemical, microbiological, and physical is conducted in a timely fashion and within an approved, established framework (SOPs, customers requirements, etc. . Ensure that each finished products disposition reflects the company's commitments to integrity and quality. Validation: generate functional, technically sound validation plans/protocols (process and cleaning which assure reliable and consistent process when placed into the on-going operation. Stability Program: assure the timely testing and prompt evaluation of data generated through testing (chemical and/or micro . Evaluate data to determine the products efficacy through its assigned expiration date. Procedures: assure that procedures (SOPS and operating instructions are available, and administer the documentation program for review and approval Complaints and Excursions: investigate customer/consumer complaints and in-house generated excursions (process, technical, etc. . Establish probable cause, to minimize potential impact, and/or reveal opportunities for improvement in operations (production, laboratories, etc. and manage associated CAPA. Quality as Profit Center: develop the logistics for and control of an accurate fee schedule and timely billing for company's customers (testing, managed stability program, validation, etc. . Review and revise, if necessary, tests availability and service fees to reflect most current cost and expense of services performed. Budgets: develop and manage budgets for the Quality Team supporting business initiatives and strategies. Customer Interface: develop and maintain relationships with Customers for current and future products. Qualifications Bachelor's degree Sciences (chemistry, microbiology is preferred. Advanced level degree a plus. Experience: 10+ years Wide-ranging QA/QC managerial skills, including laboratory management, and a minimum of 15 years experience and hands-on work. This experience should encompass OTC and Rx Pharmaceuticals, including NDA filed products. Thorough knowledge of FDA regulations and quality systems also required. Communication skills and the ability to interact with customers and colleagues at all levels are required.
Contact: djohnson@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
http://www.clinicaladvances.com/article_pdfs/ho0212_bailie.pdf
Bailie GR, Verhoef JJ, Clin Adv Hematol Oncol. 2012 Feb;10(2 :101-8, Albany College of Pharmacy & Health Sciences, NY
The main duties involve providing ongoing technical service to existing clients in the region.
General Duties and Responsibilities
The candidate will be expected to quickly pick up the skills required for this role as well developing knowledge of the range of products and services. The role will require independent enterprise as well as team work and the successful candidate should have excellent personal skills. Technical service reports and client presentations will also be required.
Education and Experience
A science background to at least degree level is required and experience in the water treatment industry would be advantageous, although not essential.
The candidate must be self motivated, have excellent organisational skills and be able to work to deadlines. They should also be flexible, be customer focused and have good computer skills. A clean driving license is essential.
Remuneration
Attractive compensation and benefits package available.
Please contact Tom Brine
0161 2454456
tom.brine@pulsejobs.com
Responsibilities:
- Responsible for the management of designated clinical trials including investigator selection, analysis of potential patient recruitment, preparation of trial related documentation (protocols, Case report forms, investigators brochures, consent documents, letters of agreement, confidentiality agreements , organizing Ethics committee submissions with follow through to ensure successful outcome.
- Responsible for multiple projects and must work both independently and in a team environment.
- Fill and compare the trial documentation and studies.
- Manage patient recruitment strategies to increase patient randomization into the trial (eg investigator and research nurse meetings, update newsletters, advertising, letters to GPs .
- Provide management to the clinical research assistants to ensure that their role and contribution is optimized.
- Deal with complaints and handle difficult situations that may occur throughout the clinical trial.
Qualifications:
- A bachelor's degree in a life science-related discipline
- At least 1 year on-site clinical monitoring experience
- Experience with clinical safety precautions
- Computer literate
- Willing to travel on a regular basis
Salary: Competitive
Candidates interested in this position should send updated CV to Gabriela.Kalauz@pulse jobs.com
All applications will be reviewed within 2 working days and candidates contacted shortly after.
Salary: Open
Description: Fortune 100 pharma client has multiple exciting opportunities for a Biologist/Molecular Biologist/Microbiologist proficient with Mammalian Cell Culture. Must have flexibility to accommodate working: 10 days on and 4 days off with every other weekend off. The emphasis is on cell based and virological laboratory methods, such as tissue culture safety, cell-line maintenance, and infectivity titration (potency . The successful candidate: Has knowledge of mammalian cell culture propagation and maintenance procedures and other virology laboratory practices Authors standard operating procedures (SOPs for the performance of laboratory methods Troubleshoots equipment issues as needed Initiates and contributes to laboratory investigations as needed and follows site procedures in the documentation of Quality Notifications and CAPAs Collaborates with Durham Laboratory Compliance to ensure adherence to regulatory requirements Provides active support during audits and inspections (regulatory, internal, safety Supports MMD divisional and Quality initiatives Required: B.S. degree in a science field required, preferably biology, microbiology, or biochemistry Must have good technical writing skills and high attention to detail. Must be able to work independently and within a team environment Must possess good communication skills Preferred: Knowledge of cGMPs and GLPs Root cause analysis methodology Lean Laboratory knowledge and experience Experience in analytical method transfer
Contact: dmiddleton@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Salary: $55,000 to $90,000
Description: Judge Executive Search is seeking a Validation Engineer for a pharmaceutical development and manufacturing company located in Texas. The qualified candidate is responsible for the execution and management of qualification activities for manufacturing, equipment and facilities on site. The engineer prepares and executes qualification and re-qualification activities as necessary for new and modified equipment and / or facilities so that the qualification status of site equipment is maintained at all times. The individual will prepare documentation for and adhere to FDA compliance with cGMPs .This role also assists external qualification personnel with the execution of major project qualification activities which require the use of temporary external resources. Responsibilities: Design, develop, and prepares validation protocols to challenge the mechanical and chemical processes for validation of manufacturing and packaging processes, as well as cleaning processes Design, develop, and prepare of validation protocols to challenge both mechanical and chemical processes for qualification of facilities and utilities installation (OQ and operation (OQ Analyze equipment performance against stated performance criteria Ensure all company and Site Validation policies and procedures are adhered to Ensure all work carried out and equipment installed is safe, effective and in compliance with the appropriate industry standards Ensure all work undertaken is reflected accurately in up to date Validation / project information files Lead the development of equipment and / or facility qualification protocols and ensure they are in line with Validation policies and guidance documents in accordance with FDA compliance Review data in support of validation efforts Lead the execution of qualification protocols on facilities and equipment as necessary. Ensure the maintenance of a qualification document listing for all qualified equipment on site. Ensure all qualification documentation is maintained up to date at all times. Provide expert guidance for the resolution of technical issues arising during the execution of qualification activities. Coordinates validation activities with other groups Perform special projects as needed Qualifications: Bachelors degree required. Engineering degree required. Mechanical or Chemical Engineering, Science, or related field preferred Strong leadership, organizational planning, and project management skills. Excellent interpersonal effectiveness and communication skills (written and oral . Ability to work with a cross functional team to achieve expected results.
Contact: djohnson@judge.com
This job and many more are available through The Judge Group. Find us on the web at www.judge.com
North East
?25,000 - ?35,000
My client is an established contract research company, due to ongoing demand they are no searching for a Synthetic Organic Chemist to join their team as a Senior Research Scientist. This role will be based at their laboratory and manufacturing plant in the North East of England.
This role involves predominantly nonGMP and GMP lab based synthesis up to 20L with occasional supervision of pilot plant activities up to 400L. This role will involve frequent direct contact with clients, from big pharma to speciality chemical companies or other contract research organisations.
The successful candidate for this role will ideally hold a PhD in Organic Chemistry and have experience within a small scale development laboratory. Experience of route scouting, synthesis and scale up, preferably from a contract research background is preferred. Excellent synthetic skills are a must at small scale, and the following skills would be an advantage.
· Design of experiments and MODDE software
· GC and HPLC instrumentation experience
· Broad synthetic experience through homogeneous metal catalysis, natural product or heterocyclic experience.
· Flash chromatography experience.
· Salt of Polymoroph screening.
If you are interested in applying for this position please forward your CV to Brendan Rogers at PULSE Life Sciences.
No comments:
Post a Comment